Notice Number: NOT-OD-07-058
Update: The following update relating to this announcement has been issued:
- August 9, 2007 - See Notice (NOT-OD-07-083) Full Implementation to Shorten the Review Cycle for New Investigator R01 Applications.
Key Dates
Release Date April 4, 2007
Issued by
Office of the Director
National Institutes of Health (NIH) (http://www.nih.gov/)
Center for Scientific Review (http://www.csr.nih.gov)
Purpose
As part of the National Institutes of Health continuing commitment to new investigators, a pilot effort (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-013.html) was begun in 2006 to allow new investigators to have the option of submitting a resubmission/amended R01 application for consecutive review cycles, saving four months. This pilot was extended to twenty two additional study sections in January of 2007 (http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-07-034.html). The three cycles of the pilot have involved nearly 1800 R01 applications reviewed in the original 40 study sections in the Center for Scientific Review. Approximately 13% of the eligible new investigators have used the option of next cycle submission.
The Center for Scientific Review is committed to continuing this pilot for the current study sections and to the extension to all new investigator R01 applications by the end of 2007. For the May/June 2007 review meetings the forty-six study sections listed at the end of this document will be added to the pilot. By the September/October 2007 meetings all CSR study sections reviewing new investigator R01 applications submitted for standard receipt dates (this does not include RFAs and PARs with special dates) will meet on a schedule to allow consecutive cycle resubmissions. Study Sections in the AIDS and AIDS Related Research (AARR) IRG already conduct reviews and produce summary statements on a schedule that allows consecutive cycle submission for new investigator R01s.
With the expansion of this effort, the policies and practices initially established remain in effect:
- Study Sections participating will schedule meetings so that new investigators receive their summary statements no later than March 1, July 1, or November 1.
- The Summary Statements for qualifying applications will have an explicit note indicating eligibility for next cycle submission.
- Resubmission applications for consideration at the next cycle must be submitted by March 20, July 20, or November 20.
- Resubmission applications must be reviewed by the same study section that reviewed the previous version.
- New Investigators who do not choose the next cycle option or request review by a different study section will use the standard resubmission dates for subsequent cycle submission (March 5, July 5, or November 5).
As a reminder effective February 5, 2007, all R01 applications are submitted electronically via Grants.gov using the SF424RR forms (http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-07-020.html).
The NIH definition of a new investigator remains unchanged:
For the purposes of review and funding, applicants are considered new investigators if they have not previously served as the Principal Investigators (PI) on any Public Health Service-supported research project other than a small grant (R03), an Academic Research Enhancement Award (R15), an exploratory/developmental grant (R21), or certain research career awards directed principally to physicians, dentists, or veterinarians at the beginning of their research career (K01, K08, K22, K23, K25, and K99/R00). Current or past recipients of Independent Scientist and other non-mentored career award (K02, K04, K05, K24, and K26) are not considered new investigators. http://grants1.nih.gov/grants/new_investigators/resources.htm
Inquiries
For further information please contact:
Division of Receipt and Referral
Center for Scientific Review
301-435-0715; 301-480-1987 (fax)
The study sections participating for May/June 2007 reviews are (additions to the previous 62 are in bold font):
Adult Psychopathology and Disorders of Aging Study Section (APDA)
Aging Systems and Geriatrics Study Section (ASG)
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Auditory System Study Section (AUD)
Basic Mechanisms of Cancer Therapeutics Study Section (BMCT)
Biobehavioral Regulation, Learning and Ethology Study Section (BRLE)
Biochemistry and Biophysics of Membranes Study Section [BBM]
Biodata Management and Analysis Study Section [BDMA]
Bioengineering, Technology, and Surgical Sciences Study Section [BTSS]
Biological Rhythms and Sleep Study Section (BRS)
Biomaterials and Biointerfaces Study Section (BMBI)
Biomedical Computing and Health Informatics Study Section (BCHI)
Biomedical Imaging Technology Study Section [BMIT]
Biology and Diseases of the Posterior Eye Study Section (BDPE)
Biostatistical Methods and Research Design Study Section (BMRD)
Cancer Etiology Study Section (CE)
Cancer Genetics Study Section (CG)
Cancer Immunopathology and Immunotherapy Study Section (CII)
Cancer Molecular Pathobiology Study Section [CAMP]
Cardiovascular and Sleep Epidemiology Study Section [CASE]
Cell Structure and Function Study Section (CSF)
Cellular and Molecular Biology of the Kidney Study Section (CMBK)
Cellular and Molecular Biology of Neurodegeneration Study Section (CMND)
Cellular and Molecular Immunopathology A Study Section (CMIA)
Cellular Aspects of Diabetes and Obesity Study Section [CADO]
Cellular Mechanisms in Aging and Development Study Section (CMAD)
Cellular Signaling and Regulatory Systems Study Section (CSRS)
Chemo/Dietary Prevention Study Section (CDP)
Clinical and Integrative Cardiovascular Sciences Study Section (CICS)
Clinical and Integrative Diabetes and Obesity Study Section [CIDO]
Clinical and Integrative Gastrointestinal Pathobiology Study Section [CIGP]
Clinical Research and Field Studies of Infectious Diseases Study Section [CRFS]
Cognition and Perception Study Section (CP)
Cognitive Neuroscience Study Section (COG)
Community Influences on Health Behavior Study Section [CIHB]
Community-Level Health Promotion Study Section [CLHP]
Development 1 Study Section (DEV1)
Development 2 Study Section (DEV2)
Developmental Therapeutics Study Section (DT)
Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section [DDR]
Drug Discovery and Molecular Pharmacology (DMP)
Electrical Signaling, Ion Transport and Arrhythmias Study Section (ESTA)
Enabling Bioanalytical and Biophysical Technologies Study Section [EBT]
Epidemiology of Cancer Study Section (EPIC)
Erythocyte and Leukocyte Biology Study Section (ELB)
Gastrointestinal Cell and Molecular Biology Study Section [GCMB]
Gastrointestinal Mucosal Pathobiology Study Section [GMPB]
Gene and Drug Delivery Systems Study Section [GDD]
Gene Therapy and Inborn Errors Special Emphasis Panel [GTIE]
Genetic Variation and Evolution Study Section [GVE]
Genetics of Health and Disease Study Section (GHD)
Genomics, Computational Biology and Technology Study Section [GCAT]
Hepatobiliary Pathophysiology Study Section [HBPP]
Hypersensitivity, Autoimmune and Autoimmune Diseases Study Section (HAI)
Hypertension and Microcirculation Study Section (HM)
Immunity and Host Defense Study Section (IHD)
Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section [IRAP]
Integrative and Clinical Endocrinology and Reproduction Study Section [ICER]
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Intracellular Interactions Study Section (ICI)
Language and Communication Study Section LCOM)
Lung Cellular, Molecular and Immunobiology Study Section [LCMI]
Lung Injury, Repair and Remodeling Study Section [LIRR]
Macromolecular Structure and Function A Study Section [MSFA]
Macromolecular Structure and Function B Study Section (MSFB)
Macromolecular Structure and Function C Study Section [MSFC]
Macromolecular Structure and Function D Study Section (MSFD)
Macromolecular Structure and Function E Study Section (MSFE)
Medical Imaging Study Section [MEDI]
Membrane Biology and Protein Processing Study Section (MBPP)
Molecular and Integrative Signal Transduction Study Section (MIST)
Molecular Genetics A Study Section [MGA]
Molecular Genetics B Study Section [MGB]
Molecular Genetics C Study Section [MGC]
Molecular Oncogenesis Study Section (MONC)
Motor Function, Speech and Rehabilitation Study Section (MFSR)
Myocardial Ischemia and Metabolism Study Section (MIM)
Neural Oxidative Metabolism and Death (NOMD)
Neurobiology of Learning and Memory Study Section (LAM)
Neurobiology of Motivated Behavior Study Section (NMB)
Neurodegeneration, Plasticity and Regeneration Study Section (NDPR)
Neuroendocrinology, Neuroimmunology, and Behavior Study Section (NNB)
Neurogenesis and Cell Fate Study Section (NCF)
Nursing Science: Adults and Older Adults Study Section (NSAA)
Nursing Science: Children and Families Study Section [NSCF]
Oral, Dental, and Craniofacial Sciences Study Section (ODCS)
Pathogenic Eukaryotes Study Section [PTHE]
Pregnancy and Neonatology Study Section (PN)
Prokaryotic Cell and Molecular Biology Study Section (PCMB)
Psychosocial Development, Risk and Prevention Study Section (PDRP)
Psychosocial Risk and Disease Prevention Study Section (PRDP)
Radiation Therapeutics and Biology Study Section (RTB)
Respiratory Integrative Biology and Translational Research Study Section [RIBT]
Risk Prevention and Intervention for Addictions Study Section (RIPA)
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Skeletal Muscle and Exercise Physiology Study Section (SMEP)
Social Sciences and Population Studies Study Section [SSPS]
Surgery, Anesthesiology, and Trauma Study Section [SAT]
Synapses, Cytoskeleton, and Trafficking Study Section (SYN)
Synthetic and Biological Chemistry A Study Section [SBCA]
Synthetic and Biological Chemistry B Study Section [SBCB]
Transplantation, Tolerance, and Tumor Immunology Study Section (TTT)
Tumor Microenvironment Study Section (TME)
Tumor Progression and Metastasis Study Section [TPM]
Vaccines Against Microbial Diseases Study Section (VMD)
Vascular Cell and Molecular Biology Study Section (VCMB)
Virology A Study Section (VIRA)
Xenobiotic and Nutrient Disposition and Action Study Section [XNDA]
and Human Services (HHS)
